Advocacy

ACTA negotiates and advocates on behalf of the clinical trials sector with governments, health care policymakers and consumers on issues that impact the conduct of investigator-initiated clinical trials across the Australian health system.

Greater engagement and partnership between policymakers and clinical researchers significantly improves the process of generating high-quality evidence for new and existing clinical therapies at low marginal cost or with cost-savings.